DolCas Biotech
DolCas Biotech is a private B2B branded nutraceutical ingredients company that develops and commercializes eight clinically-backed botanical and marine-derived extracts for dietary supplement and functional food/beverage manufacturers, supported by vertically integrated manufacturing in India.
- Company typePrivate
- Founded2007
- HeadquartersLanding, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What DolCas Biotech does
DolCas Biotech is a private B2B branded nutraceutical ingredients company headquartered in Landing, New Jersey, founded in 2007. The firm develops, manufactures, and commercializes proprietary botanical and marine-derived ingredient formulations sold to dietary supplement manufacturers and functional food/beverage producers. Its portfolio comprises eight branded ingredient SKUs — TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, NitrateBurst, and Ginfort — each supported by clinical studies, patent applications or proprietary process IP, and regulatory credentials including GRAS, USDA Organic, EU Organic, and Zero-Carbon certification for TruOliv. The core technical differentiation rests on proprietary processing technologies, including water-dispersible curcumin (Curcugen), hydroxytyrosol-rich olive fruit extract (TruOliv), and enzyme-hydrolyzed chicken cartilage type II collagen (Fortiquin), with clinical positioning around bioavailability enhancement and structure-function claims.
Manufacturing is anchored by DolCas Botanosys, a vertically integrated production arm established in 2017 in Bikaner, India, which provides proprietary raw material control and white-label contract manufacturing capability. The firm operates a sales-led B2B go-to-market with three revenue streams: branded ingredient sales, contract manufacturing services, and licensing/co-marketing arrangements. Major channel partnerships include a 2020 distribution agreement with IFF Health for Curcugen and a 2025 partnership with Cosmos Health for North American domestic manufacturing. New product formats such as the 2026 Morikol single-serving sachet target the functional food/beverage channel beyond traditional supplement capsules. Trade show presence at Vitafoods Europe and SupplySide Global supports customer acquisition. The company is privately held with no disclosed funding rounds, no public revenue, and an 11–50 employee footprint.
DolCas Biotech firmographics
Firmographics- Name
- DolCas Biotech
- Legal name
- DolCas Biotech, LLC.
- Website
- https://dolcas-biotech.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DolCas Biotech is a private B2B branded nutraceutical ingredients company that develops and commercializes eight clinically-backed botanical and marine-derived extracts for dietary supplement and functional food/beverage manufacturers, supported by vertically integrated manufacturing in India.
- Ownership category
- akta.pro rank
DolCas Biotech industry classification
Industry- Product category
- Nutraceutical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
- akta.pro primary industry
- Phytogenics & Botanicals (Essential Oils, Plant Extracts) (AFADAKAF)
- akta.pro secondary industries
- Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends) (CRADAOAO), Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes) (CRADAOAM), Herbal & Botanical Supplements (CRADAGAD)
Keywords
Where DolCas Biotech is headquartered
LocationHeadquarters
- HQ city
- Landing
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
DolCas Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Branded Ingredient Sales: Sale of proprietary branded nutraceutical ingredients including TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, and NitrateBurst to dietary supplement, functional food, and beverage manufacturers. Revenue derived from ingredient product sales with varying order quantities.
- Contract Manufacturing Services: Custom manufacturing and finishing services including liquid-filled 2-piece hard shell capsules, leveraging vertically integrated supply chain with DolCas Botanosys manufacturing facility in India. Supports customers from ideation through creation with reduced manufacturing minimums.
- Licensing and Co-Marketing Agreements: Strategic licensing and marketing partnerships such as the IFF Health partnership for Curcugen distribution. Exclusive distribution agreements and co-marketing arrangements with major ingredient distributors.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
DolCas Biotech product offering
Product offeringCore offering
DolCas Biotech develops, manufactures, and markets proprietary branded nutraceutical ingredients — botanical and marine-derived extracts — for use by dietary supplement, functional food, and beverage manufacturers. The portfolio includes eight standardized branded ingredients (TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, NitrateBurst, Ginfort) supported by clinical research, regulatory dossiers, and a vertically integrated manufacturing arm (DolCas Botanosys) in India. The company also offers custom contract manufacturing and finishing services to customers.
Product overview
DolCas Biotech offers a portfolio of branded nutraceutical ingredients focused on botanical and marine-derived extracts. The company operates with a vertically integrated structure including its own manufacturing arm DolCas Botanosys in India. The portfolio includes eight distinct branded ingredients: TruOliv® (olive polyphenols), Morikol® (marine collagen tripeptides), MMP50® (green-lipped mussel extract), Curcugen® (turmeric/curcumin), Fortiquin® (male sexual stamina blend), Bergacyn®FF (liver/metabolic health), NitrateBurst® (plant nitrates for cardiovascular support), and Ginfort® (ginger extract). These ingredients are marketed with science-backed positioning, clinical research support, and exclusivity in the marketplace, targeting dietary supplement, functional food, and beverage manufacturers.
Differentiator
Problem solved
Functional benefit
Brands
- TruOliv®: USDA and EU-certified whole olive tree extract with hydroxytyrosol and oleuropein from fruit and leaf, enriched by Saharan Desert conditions.
- Morikol®
- MMP50®
- Curcugen®
- Fortiquin®
- Bergacyn®FF
- NitrateBurst®
- Ginfort®
Products and services
- TruOliv USDA and EU-certified whole olive tree extract with hydroxytyrosol and oleuropein from fruit and leaf, sourced from Moroccan Saharan Desert conditions that enrich polyphenol content. Solvent-free, organic polyphenol extract standardized to 10% total polyphenols, 6% oleuropein, and 2% hydroxytyrosol, intended for dietary supplement and functional food manufacturers.
- Morikol Marine collagen tripeptide formula derived from fish, featuring very low molecular weight tripeptides (average 300 Da) standardized to minimum 15% tripeptide concentration, clinically proven to support skin and joint health at 1g/day dose. Tripeptides absorb intact through PEPT1 receptors; intended for supplement and functional food manufacturers.
- MMP50 New Zealand green-lipped whole-mussel extract retaining biological activity through proprietary shell extraction that avoids cooking, heating, or steaming. Standardized for bioactivity using MMP-inhibition assay, supporting joint health through MMP enzyme inhibition (MMPs 1-14); targeted at supplement manufacturers.
- Curcugen Dispersible, clinically-studied whole turmeric extract delivering 39X enhanced curcuminoid bioavailability compared to standard curcumin 95%. Oleoresin-based formula retaining turmeric-native actives including polar resins, essential oils, and curcuminoid analogues at natural ratios; GRAS self-affirmed and standardized to 50% curcuminoids for dietary supplement and food/beverage manufacturers.
- Fortiquin Patent-pending standardized 5-ingredient blend of botanical extracts (mucuna, fenugreek, ashwagandha, artichoke) and L-arginine, clinically shown to support male sexual stamina. Standardized to minimum 20% saponins and 1.5% total flavonoids; clinical study reported 5.1X improvement in endurance over placebo at 450mg twice daily.
- Bergacyn FF Patented extract blend of bergamot citrus and Cynara cardunculus clinically proven to support normal liver fat levels and healthy weight loss. Solvent-free, free-flowing formulation with 17% polyphenols and 5% cynaropicrin, effective at 600mg/day; published study reported 9.6 lbs weight loss versus 5.2 lbs placebo over 12 weeks.
- NitrateBurst Green spinach extract delivering 9% phytonitrates and 13% plant-based potassium, supporting healthy blood pressure, cardiovascular health, and athletic endurance through an oxygen-independent nitric oxide pathway. Water-soluble, solvent-free extract used in 1-2g/day dose range.
- Ginfort Patented, highly stable concentrated gingeroids extract standardized to 26% actives, solvent-free, with clinically-proven benefits in relieving symptoms of functional dyspepsia.
Quantifiable outcome
- 39X enhanced bioavailability of free curcumin vs. C-95, demonstrated in 18-subject pharmacokinetic study
- +4 more outcomes
Companies that use DolCas Biotech
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
DolCas Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
DolCas Biotech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IFF Health (International Flavors & Fragrances)flagshipIFF Health, part of International Flavors & Fragrances, partnered with DolCas Biotech on the sale and marketing of Curcugen, a next-generation, all-natural turmeric extract for both dietary supplement and food and beverage industries. IFF Health handles the commercial distribution and marketing of this branded ingredient leveraging its global ingredient distribution network.
Scale indicators3 records
Recent moves8 records
Expansion highlights5 records
DolCas Biotech competitors and assessment
Company assessmentDirect peers
- Sabinsa: Sabinsa is a leading manufacturer and global supplier of patented, science-backed branded nutraceutical ingredients (e.g., Curcumin C3 Complex, BioPerine, ForsLean) with vertically integrated manufacturing and clinical research programs, directly comparable to DolCas's branded botanical ingredient model.
- OmniActive Health Technologies: OmniActive develops proprietary, clinically studied branded nutraceutical ingredients such as Lutemax, CurcuWIN, and Capsimax, targeting dietary supplement and F&B manufacturers. It mirrors DolCas's branded botanical positioning, clinical evidence strategy, and global B2B sales approach.
- PLT Health Solutions: PLT Health Solutions is a branded ingredient supplier focused on plant-based and marine-sourced extracts backed by clinical research, selling into supplement and functional food manufacturers. Its portfolio, science-led sales motion, and exclusive-distribution approach directly parallel DolCas.
- Gencor: Gencor is a branded ingredient company offering clinically validated botanical and marine extracts (e.g., Levagen+, Gencor PEA, AquaLOX) with patent positions and global distribution, directly comparable to DolCas's branded botanical/nutraceutical ingredient strategy.
- Nutriventia: Nutriventia (an Inventia Healthcare company) supplies patented branded nutraceutical ingredients with proprietary delivery technologies targeting bioavailability and clinical efficacy, comparable to DolCas's Curcugen Self-D and Morikol tripeptide technologies.
- Lallemand Health Solutions: Lallemand Health Solutions offers branded, clinically documented probiotic and natural ingredient solutions for human health and nutrition, targeting dietary supplement and functional food manufacturers with proprietary strains and science-led positioning.
Broad incumbents
- Kerry Group: Kerry Group's Health and Life Sciences arm supplies branded bioactive ingredients, probiotics, and functional food components to global supplement and F&B manufacturers. As a multi-billion-dollar public ingredient platform, it is a broader incumbent serving overlapping customers.
- ADM (Health & Wellness): ADM's Health & Wellness division offers a broad portfolio of branded nutritional ingredients, botanicals, and functional food solutions to manufacturers globally, competing with DolCas in supplement and F&B manufacturer accounts as a large-scale incumbent.
- IFF Health (International Flavors & Fragrances): IFF Health is a global ingredient powerhouse that not only distributes DolCas's Curcugen but also develops and markets its own branded nutritional and botanical ingredients, positioning it as both a strategic partner and broad incumbent competitor in the same space.
Emerging players
- Ingredients by Nature: Ingredients by Nature supplies branded, science-backed botanical extracts (e.g., Pomella, LearnGo) for dietary supplement and functional food applications, with a comparable branded-ingredient model to DolCas but smaller portfolio and reach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
DolCas Biotech compliance and trust
Trust signalCompliance2 records
DolCas Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
DolCas Biotech leadership team
Management profileNumber of profiles
Profiles1 record
DolCas Biotech subsidiaries and ownership
Company hierarchySubsidiaries1 record
DolCas Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DolCas Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DolCas Biotech
What does DolCas Biotech do?
DolCas Biotech develops, manufactures, and markets proprietary branded nutraceutical ingredients — botanical and marine-derived extracts — for use by dietary supplement, functional food, and beverage manufacturers. The portfolio includes eight standardized branded ingredients (TruOliv, Morikol, MMP50, Curcugen, Fortiquin, Bergacyn FF, NitrateBurst, Ginfort) supported by clinical research, regulatory dossiers, and a vertically integrated manufacturing arm (DolCas Botanosys) in India. The company also offers custom contract manufacturing and finishing services to customers.
Is DolCas Biotech a public or private company?
DolCas Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DolCas Biotech founded?
DolCas Biotech was founded in 2007. It employs 11 to 50 people.
Where is DolCas Biotech based?
DolCas Biotech is headquartered in Landing, United States, in the North America region.
How does DolCas Biotech make money?
Three revenue lines are on record. Branded Ingredient Sales are the primary driver. The others are contract Manufacturing Services and licensing and Co-Marketing Agreements.
Who are DolCas Biotech's main competitors?
Direct peers on record are Sabinsa, OmniActive Health Technologies, PLT Health Solutions, Gencor, Nutriventia and Lallemand Health Solutions. Broad incumbents are Kerry Group, ADM (Health & Wellness) and IFF Health (International Flavors & Fragrances). Ingredients by Nature is listed as an emerging player.
Does DolCas Biotech have an API?
No public API is recorded for DolCas Biotech.
What industry is DolCas Biotech in?
DolCas Biotech's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is AFADAKAF, Phytogenics & Botanicals (Essential Oils, Plant Extracts), with a secondary code of CRADAOAO, Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends). Its NAICS code is 325411 and its SIC code is 2833.